Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lakshmi Dhevi N. Selvan is active.

Publication


Featured researches published by Lakshmi Dhevi N. Selvan.


Nature | 2014

A draft map of the human proteome

Min Sik Kim; Sneha M. Pinto; Derese Getnet; Raja Sekhar Nirujogi; Srikanth S. Manda; Raghothama Chaerkady; Dhanashree S. Kelkar; Ruth Isserlin; Shobhit Jain; Joji Kurian Thomas; Babylakshmi Muthusamy; Pamela Leal-Rojas; Praveen Kumar; Nandini A. Sahasrabuddhe; Lavanya Balakrishnan; Jayshree Advani; Bijesh George; Santosh Renuse; Lakshmi Dhevi N. Selvan; Arun H. Patil; Vishalakshi Nanjappa; Aneesha Radhakrishnan; Samarjeet Prasad; Tejaswini Subbannayya; Rajesh Raju; Manish Kumar; Sreelakshmi K. Sreenivasamurthy; Arivusudar Marimuthu; Gajanan Sathe; Sandip Chavan

The availability of human genome sequence has transformed biomedical research over the past decade. However, an equivalent map for the human proteome with direct measurements of proteins and peptides does not exist yet. Here we present a draft map of the human proteome using high-resolution Fourier-transform mass spectrometry. In-depth proteomic profiling of 30 histologically normal human samples, including 17 adult tissues, 7 fetal tissues and 6 purified primary haematopoietic cells, resulted in identification of proteins encoded by 17,294 genes accounting for approximately 84% of the total annotated protein-coding genes in humans. A unique and comprehensive strategy for proteogenomic analysis enabled us to discover a number of novel protein-coding regions, which includes translated pseudogenes, non-coding RNAs and upstream open reading frames. This large human proteome catalogue (available as an interactive web-based resource at http://www.humanproteomemap.org) will complement available human genome and transcriptome data to accelerate biomedical research in health and disease.


PLOS Medicine | 2009

A Compendium of Potential Biomarkers of Pancreatic Cancer

H. C. Harsha; Kumaran Kandasamy; Prathibha Ranganathan; Sandhya Rani; Subhashri Ramabadran; Sashikanth Gollapudi; Lavanya Balakrishnan; Sutopa B. Dwivedi; Deepthi Telikicherla; Lakshmi Dhevi N. Selvan; Renu Goel; Suresh Mathivanan; Arivusudar Marimuthu; Manoj Kumar Kashyap; Robert F. Vizza; Robert J. Mayer; James A. DeCaprio; Sudhir Srivastava; Samir M. Hanash; Ralph H. Hruban; Akhilesh Pandey

Akhilesh Pandey and colleagues describe a compendium of potential biomarkers that can be systematically validated by the pancreatic cancer community.


Molecular BioSystems | 2010

Identifying targets of miR-143 using a SILAC-based proteomic approach.

Yi Yang; Raghothama Chaerkady; Kumaran Kandasamy; Tai Chung Huang; Lakshmi Dhevi N. Selvan; Sutopa B. Dwivedi; Oliver A. Kent; Joshua T. Mendell; Akhilesh Pandey

Although the targets of most miRNAs have not been experimentally identified, microRNAs (miRNAs) have begun to be extensively characterized in physiological, developmental and disease-related contexts in recent years. Thus far, mainly computational approaches have been employed to predict potential targets for the large majority of miRNAs. Although miRNAs exert a major influence on the efficiency of translation of their targets in animals, most studies describing experimental identification of miRNA target genes are based on detection of altered mRNA levels. miR-143 is a miRNA involved in tumorigenesis in multiple types of cancer, smooth muscle cell fate and adipocyte differentiation. Only a few miR-143 targets are experimentally verified, so we employed a SILAC-based quantitative proteomic strategy to systematically identify potential targets of miR-143. In total, we identified >1200 proteins from MiaPaCa2 pancreatic cancer cells, of which 93 proteins were downregulated >2-fold in miR-143 mimic transfected cells as compared to controls. Validation of 34 of these candidate targets in luciferase assays showed that 10 of them were likely direct targets of miR-143. Importantly, we also carried out gene expression profiling of the same cells and observed that the majority of the candidate targets identified by proteomics did not show a concomitant decrease in mRNA levels confirming that miRNAs affect the expression of most targets through translational inhibition. Our study clearly demonstrates that quantitative proteomic approaches are important and necessary for identifying miRNA targets.


Nucleic Acids Research | 2009

RAPID: Resource of Asian Primary Immunodeficiency Diseases

Shivakumar Keerthikumar; Rajesh Raju; Kumaran Kandasamy; Atsushi Hijikata; Subhashri Ramabadran; Lavanya Balakrishnan; Mukhtar Ahmed; Sandhya Rani; Lakshmi Dhevi N. Selvan; Devi S. Somanathan; Somak Ray; Mitali Bhattacharjee; Sashikanth Gollapudi; Yl Ramachandra; Sahely Bhadra; Chiranjib Bhattacharyya; Kohsuke Imai; Shigeaki Nonoyama; Hirokazu Kanegane; Toshio Miyawaki; Akhilesh Pandey; Osamu Ohara; S. Sujatha Mohan

Availability of a freely accessible, dynamic and integrated database for primary immunodeficiency diseases (PID) is important both for researchers as well as clinicians. To build a PID informational platform and also as a part of action to initiate a network of PID research in Asia, we have constructed a web-based compendium of molecular alterations in PID, named Resource of Asian Primary Immunodeficiency Diseases (RAPID), which is available as a worldwide web resource at http://rapid.rcai.riken.jp/. It hosts information on sequence variations and expression at the mRNA and protein levels of all genes reported to be involved in PID patients. The main objective of this database is to provide detailed information pertaining to genes and proteins involved in primary immunodeficiency diseases along with other relevant information about protein–protein interactions, mouse studies and microarray gene-expression profiles in various organs and cells of the immune system. RAPID also hosts a tool, mutation viewer, to predict deleterious and novel mutations and also to obtain mutation-based 3D structures for PID genes. Thus, information contained in this database should help physicians and other biomedical investigators to further investigate the role of these molecules in PID.


Journal of Proteome Research | 2012

Proteogenomic analysis of Candida glabrata using high resolution mass spectrometry.

T.S.K.a b c d Prasad; H. C. Harsha; Shivakumar Keerthikumar; Nirujogi Raja Sekhar; Lakshmi Dhevi N. Selvan; P.a d Kumar; Sneha M. Pinto; Babylakshmi Muthusamy; Yashwanth Subbannayya; Santosh Renuse; Raghothama Chaerkady; Premendu P. Mathur; Raju Ravikumar; Akhilesh Pandey

Candida glabrata is a common opportunistic human pathogen leading to significant mortality in immunosuppressed and immunodeficient individuals. We carried out proteomic analysis of C. glabrata using high resolution Fourier transform mass spectrometry with MS resolution of 60,000 and MS/MS resolution of 7500. On the basis of 32,453 unique peptides identified from 118,815 peptide-spectrum matches, we validated 4421 of the 5283 predicted protein-coding genes (83%) in the C. glabrata genome. Further, searching the tandem mass spectra against a six frame translated genome database of C. glabrata resulted in identification of 11 novel protein coding genes and correction of gene boundaries for 14 predicted gene models. A subset of novel protein-coding genes and corrected gene models were validated at the transcript level by RT-PCR and sequencing. Our study illustrates how proteogenomic analysis enabled by high resolution mass spectrometry can enrich genome annotation and should be an integral part of ongoing genome sequencing and annotation efforts.


Molecular & Cellular Proteomics | 2014

Annotation of the Zebrafish Genome through an Integrated Transcriptomic and Proteomic Analysis

Dhanashree S. Kelkar; Elayne Provost; Raghothama Chaerkady; Babylakshmi Muthusamy; Srikanth S. Manda; Tejaswini Subbannayya; Lakshmi Dhevi N. Selvan; Chieh-Huei Wang; Keshava K. Datta; Sunghee Woo; Sutopa B. Dwivedi; Santosh Renuse; Derese Getnet; Tai Chung Huang; Min-Sik Kim; Sneha M. Pinto; Christopher J. Mitchell; Praveen Kumar; Jyoti Sharma; Jayshree Advani; Gourav Dey; Lavanya Balakrishnan; Nazia Syed; Vishalakshi Nanjappa; Yashwanth Subbannayya; Renu Goel; T. S. Keshava Prasad; Vineet Bafna; Ravi Sirdeshmukh; Harsha Gowda

Accurate annotation of protein-coding genes is one of the primary tasks upon the completion of whole genome sequencing of any organism. In this study, we used an integrated transcriptomic and proteomic strategy to validate and improve the existing zebrafish genome annotation. We undertook high-resolution mass-spectrometry-based proteomic profiling of 10 adult organs, whole adult fish body, and two developmental stages of zebrafish (SAT line), in addition to transcriptomic profiling of six organs. More than 7,000 proteins were identified from proteomic analyses, and ∼69,000 high-confidence transcripts were assembled from the RNA sequencing data. Approximately 15% of the transcripts mapped to intergenic regions, the majority of which are likely long non-coding RNAs. These high-quality transcriptomic and proteomic data were used to manually reannotate the zebrafish genome. We report the identification of 157 novel protein-coding genes. In addition, our data led to modification of existing gene structures including novel exons, changes in exon coordinates, changes in frame of translation, translation in annotated UTRs, and joining of genes. Finally, we discovered four instances of genome assembly errors that were supported by both proteomic and transcriptomic data. Our study shows how an integrative analysis of the transcriptome and the proteome can extend our understanding of even well-annotated genomes.


Journal of Proteomics | 2014

Phosphoproteome of Cryptococcus neoformans

Lakshmi Dhevi N. Selvan; Santosh Renuse; Jyothi Embekkat Kaviyil; Jyoti Sharma; Sneha M. Pinto; Soujanya D. Yelamanchi; Vinuth N. Puttamallesh; Raju Ravikumar; Akhilesh Pandey; T. S. Keshava Prasad; H. C. Harsha

UNLABELLED Cryptococcus neoformans is an encapsulated pathogenic yeast, which causes life threatening meningitis in immunocompromised individuals. C. neoformans var. grubii is the most prevalent and virulent form among the two varieties of C. neoformans - C. neoformans var. grubii and C. neoformans var. neoformans. The virulence of C. neoformans is mainly conferred by its capsule and melanin. cAMP dependent PKA-induced phosphorylation events are reported to be associated with the expression of these virulence traits, which highlights the importance of phosphoproteins in virulence and infection. Therefore, we performed global profiling of phosphoproteome of C. neoformans to enable a better understanding of molecular regulation of its virulence and pathogenesis. High resolution mass spectrometry of TiO2 enriched phosphopeptides from C. neoformans var. grubii grown in culture led to the identification of 1089 phosphopeptides derived from 648 proteins including about 45 kinases. Motif enrichment analysis revealed that most CDK family substrates were found to be phosphorylated. This indicates that cyclin-dependent kinases were among the active kinases in the pathogen in culture. These studies provide a framework for understanding virulence mechanisms in the context of signalling pathways in pathogenic yeast. This article is part of a Special Issue entitled: Trends in Microbial Proteomics. BIOLOGICAL SIGNIFICANCE C. neoformans is a pathogenic yeast responsible for cryptococcal meningitis. Melanin and polysaccharide capsule have been established as some of the key virulence factors that play a major role in the pathogenesis of C. neoformans. Recent studies have shown the role of kinase mediated signalling pathways in governing biosynthesis of these virulence factors. This study revealed 1540 phosphorylation sites in 648 proteins providing a comprehensive view of phosphoproteins in C. neoformans. This should serve as a useful resource to explore activated signalling pathways in C. neoformans and their association with its virulence and pathogenesis.


Clinical Proteomics | 2013

Quantitative proteomics for identifying biomarkers for Rabies.

Abhilash Venugopal; S Sameer Kumar Ghantasala; Lakshmi Dhevi N. Selvan; Anita Mahadevan; Santosh Renuse; Praveen Kumar; Harsh Pawar; Nandini A Sahasrabhuddhe; Mooriyath S Suja; Yl Ramachandra; Thottethodi Subrahmanya Keshava Prasad; Shampur N Madhusudhana; H. C. Harsha; Raghothama Chaerkady; Parthasarathy Satishchandra; Akhilesh Pandey; Susarla K. Shankar

IntroductionRabies is a fatal acute viral disease of the central nervous system, which is a serious public health problem in Asian and African countries. Based on the clinical presentation, rabies can be classified into encephalitic (furious) or paralytic (numb) rabies. Early diagnosis of this disease is particularly important as rabies is invariably fatal if adequate post exposure prophylaxis is not administered immediately following the bite.MethodsIn this study, we carried out a quantitative proteomic analysis of the human brain tissue from cases of encephalitic and paralytic rabies along with normal human brain tissues using an 8-plex isobaric tags for relative and absolute quantification (iTRAQ) strategy.Results and conclusionWe identified 402 proteins, of which a number of proteins were differentially expressed between encephalitic and paralytic rabies, including several novel proteins. The differentially expressed molecules included karyopherin alpha 4 (KPNA4), which was overexpressed only in paralytic rabies, calcium calmodulin dependent kinase 2 alpha (CAMK2A), which was upregulated in paralytic rabies group and glutamate ammonia ligase (GLUL), which was overexpressed in paralytic as well as encephalitic rabies. We validated two of the upregulated molecules, GLUL and CAMK2A, by dot blot assays and further validated CAMK2A by immunohistochemistry. These molecules need to be further investigated in body fluids such as cerebrospinal fluid in a larger cohort of rabies cases to determine their potential use as antemortem diagnostic biomarkers in rabies. This is the first study to systematically profile clinical subtypes of human rabies using an iTRAQ quantitative proteomics approach.


Journal of Proteome Research | 2014

Functional annotation of proteome encoded by human chromosome 22

Sneha M. Pinto; Srikanth S. Manda; Min Sik Kim; Kyonese Taylor; Lakshmi Dhevi N. Selvan; Lavanya Balakrishnan; Tejaswini Subbannayya; Fangfei Yan; T. S. Keshava Prasad; Harsha Gowda; Charles Lee; William S. Hancock; Akhilesh Pandey

As part of the chromosome-centric human proteome project (C-HPP) initiative, we report our progress on the annotation of chromosome 22. Chromosome 22, spanning 51 million base pairs, was the first chromosome to be sequenced. Gene dosage alterations on this chromosome have been shown to be associated with a number of congenital anomalies. In addition, several rare but aggressive tumors have been associated with this chromosome. A number of important gene families including immunoglobulin lambda locus, Crystallin beta family, and APOBEC gene family are located on this chromosome. On the basis of proteomic profiling of 30 histologically normal tissues and cells using high-resolution mass spectrometry, we show protein evidence of 367 genes on chromosome 22. Importantly, this includes 47 proteins, which are currently annotated as “missing” proteins. We also confirmed the translation start sites of 120 chromosome 22-encoded proteins. Employing a comprehensive proteogenomics analysis pipeline, we provide evidence of novel coding regions on this chromosome which include upstream ORFs and novel exons in addition to correcting existing gene structures. We describe tissue-wise expression of the proteins and the distribution of gene families on this chromosome. These data have been deposited to ProteomeXchange with the identifier PXD000561.


Clinical Proteomics | 2014

Proteogenomic analysis of pathogenic yeast Cryptococcus neoformans using high resolution mass spectrometry

Lakshmi Dhevi N. Selvan; Jyothi Embekkat Kaviyil; Raja Sekhar Nirujogi; Babylakshmi Muthusamy; Vinuth N. Puttamallesh; Tejaswini Subbannayya; Nazia Syed; Aneesha Radhakrishnan; Dhanashree S. Kelkar; Sartaj Ahmad; Sneha M. Pinto; Praveen Kumar; Bipin G. Nair; Aditi Chatterjee; Akhilesh Pandey; Raju Ravikumar; Harsha Gowda; Thottethodi Subrahmanya Keshava Prasad

BackgroundCryptococcus neoformans, a basidiomycetous fungus of universal occurrence, is a significant opportunistic human pathogen causing meningitis. Owing to an increase in the number of immunosuppressed individuals along with emergence of drug-resistant strains, C. neoformans is gaining importance as a pathogen. Although, whole genome sequencing of three varieties of C. neoformans has been completed recently, no global proteomic studies have yet been reported.ResultsWe performed a comprehensive proteomic analysis of C. neoformans var. grubii (Serotype A), which is the most virulent variety, in order to provide protein-level evidence for computationally predicted gene models and to refine the existing annotations. We confirmed the protein-coding potential of 3,674 genes from a total of 6,980 predicted protein-coding genes. We also identified 4 novel genes and corrected 104 predicted gene models. In addition, our studies led to the correction of translational start site, splice junctions and reading frame used for translation in a number of proteins. Finally, we validated a subset of our novel findings by RT-PCR and sequencing.ConclusionsProteogenomic investigation described here facilitated the validation and refinement of computationally derived gene models in the intron-rich genome of C. neoformans, an important fungal pathogen in humans.

Collaboration


Dive into the Lakshmi Dhevi N. Selvan's collaboration.

Top Co-Authors

Avatar

Akhilesh Pandey

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Santosh Renuse

Amrita Vishwa Vidyapeetham

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Raghothama Chaerkady

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Anita Mahadevan

National Institute of Mental Health and Neurosciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge